Efficacy of Madhav Rasayan Plus as adjuvant in moderate COVID-19 patients: Preliminary outcomes of randomized controlled trial.
- DOI
- 10.1016/j.jaim.2022.100590
- Published
- 2022 Jul-Sep
- Container
- Journal of Ayurveda and integrative medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaim.2022.100590,
title = {Efficacy of Madhav Rasayan Plus as adjuvant in moderate COVID-19 patients: Preliminary outcomes of randomized controlled trial.},
author = {Jamadagni S and Pandkar P and Saundankar T and Shirke G and Malekar S and Vaidya VG},
year = {2022},
journal = {Journal of Ayurveda and integrative medicine},
doi = {10.1016/j.jaim.2022.100590},
url = {https://doi.org/10.1016/j.jaim.2022.100590}
}RIS
TY - JOUR TI - Efficacy of Madhav Rasayan Plus as adjuvant in moderate COVID-19 patients: Preliminary outcomes of randomized controlled trial. AU - Jamadagni S AU - Pandkar P AU - Saundankar T AU - Shirke G AU - Malekar S AU - Vaidya VG PY - 2022 JO - Journal of Ayurveda and integrative medicine DO - 10.1016/j.jaim.2022.100590 UR - https://doi.org/10.1016/j.jaim.2022.100590 ER -
APA
S, J., P, P., T, S., G, S., S, M., & VG, V. (2022). Efficacy of Madhav Rasayan Plus as adjuvant in moderate COVID-19 patients: Preliminary outcomes of randomized controlled trial.. Journal of Ayurveda and integrative medicine. https://doi.org/10.1016/j.jaim.2022.100590
Source records
- pubmed · retrieved 2026-09-26T17:56:49.557Z